AXL TYROSINE KINASE INHIBITORS AND METHODS OF MAKING AND USING THE SAME

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150184137A1
SERIAL NO

14584555

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are novel inhibitors of the Axl receptor tyrosine kinase (RTK) and methods of using such inhibitors in a variety of therapeutic approaches in the areas of cancer therapy and anti-thrombosis (anti-clotting) therapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE1800 GRANT STREET 8TH FLOOR DENVER CO 80203

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
GRAHAM, Douglas Kim Aurora, US 8 48
SATHER, Susan Louise Denver, US 6 47

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation